Expand EPRX Menu
EPRX MENU

EPRX Stock Posts


EPRX #EupraxiaPharmaceuticals stock declines -7.7% in premarket,

Premarket Decliner

EPRX Eupraxia Pharmaceuticals5.75+0.01+0.2%

Premarket:5.31-0.44 (-7.7%)

Eupraxia Pharmaceuticals Announces Positive Data from Highest-Dose Cohort in the Ongoing RESOLVE Trial in Eosinophilic Esophagitis, and Plans for Expansion of EP-104GI Development Programs

Globe NewswireMon, 29-Sep 5:00 PM
EPRX #EupraxiaPharmaceuticals stock increases 40.3% after hours.

After Hours Gainer

EPRX Eupraxia Pharmaceuticals5.75+0.01+0.2%

After Hours:8.07+2.32 (+40.4%)

Eupraxia Pharmaceuticals Announces Positive Data from Highest-Dose Cohort in the Ongoing RESOLVE Trial in Eosinophilic Esophagitis, and Plans for Expansion of EP-104GI Development Programs

Globe NewswireMon, 29-Sep 5:00 PM
EPRX #EupraxiaPharmaceuticals stock declines -9.8% in premarket,

Premarket Decliner

EPRX Eupraxia Pharmaceuticals6.65+0.69+11.6%

Premarket:6.00-0.65 (-9.8%)

Eupraxia Pharmaceuticals Announces Pricing of US$70 Million Public Offering of Common Shares

Globe NewswireMon, 22-Sep 10:42 PM
EPRX #EupraxiaPharmaceuticals stock declines -6.9% in after hours trading. See the latest news.

After Hours Decliner

EPRX Eupraxia Pharmaceuticals6.65+0.69+11.6%

After Hours:6.19-0.46 (-6.9%)

Eupraxia Pharmaceuticals Announces Proposed Public Offering of Common Shares

Globe NewswireMon, 22-Sep 4:01 PM
Load Earlier Posts
Market Data Delayed 15 Minutes